Literature DB >> 24106303

De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts.

Jiang Zhu1, Xueling Wu, Baoshan Zhang, Krisha McKee, Sijy O'Dell, Cinque Soto, Tongqing Zhou, Joseph P Casazza, James C Mullikin, Peter D Kwong, John R Mascola, Lawrence Shapiro.   

Abstract

Next-generation sequencing of antibody transcripts provides a wealth of data, but the ability to identify function-specific antibodies solely on the basis of sequence has remained elusive. We previously characterized the VRC01 class of antibodies, which target the CD4-binding site on gp120, appear in multiple donors, and broadly neutralize HIV-1. Antibodies of this class have developmental commonalities, but typically share only ∼50% amino acid sequence identity among different donors. Here we apply next-generation sequencing to identify VRC01 class antibodies in a new donor, C38, directly from B cell transcript sequences. We first tested a lineage rank approach, but this was unsuccessful, likely because VRC01 class antibody sequences were not highly prevalent in this donor. We next identified VRC01 class heavy chains through a phylogenetic analysis that included thousands of sequences from C38 and a few known VRC01 class sequences from other donors. This "cross-donor analysis" yielded heavy chains with little sequence homology to previously identified VRC01 class heavy chains. Nonetheless, when reconstituted with the light chain from VRC01, half of the heavy chain chimeric antibodies showed substantial neutralization potency and breadth. We then identified VRC01 class light chains through a five-amino-acid sequence motif necessary for VRC01 light chain recognition. From over a million light chain sequences, we identified 13 candidate VRC01 class members. Pairing of these light chains with the phylogenetically identified C38 heavy chains yielded functional antibodies that effectively neutralized HIV-1. Bioinformatics analysis can thus directly identify functional HIV-1-neutralizing antibodies of the VRC01 class from a sequenced antibody repertoire.

Entities:  

Keywords:  DNA sequencing; antibodyomics; cross-donor phylogenetic analysis; humoral immune response; sequence signature

Mesh:

Substances:

Year:  2013        PMID: 24106303      PMCID: PMC3808619          DOI: 10.1073/pnas.1306262110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Next-generation genomics: an integrative approach.

Authors:  R David Hawkins; Gary C Hon; Bing Ren
Journal:  Nat Rev Genet       Date:  2010-07       Impact factor: 53.242

Review 2.  Progress in modeling of protein structures and interactions.

Authors:  Ora Schueler-Furman; Chu Wang; Phil Bradley; Kira Misura; David Baker
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

Review 3.  X-ray crystallographic analysis of free and antigen-complexed Fab fragments to investigate structural basis of immune recognition.

Authors:  I A Wilson; J M Rini; D H Fremont; G G Fieser; E A Stura
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 4.  Next-generation DNA sequencing methods.

Authors:  Elaine R Mardis
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

5.  Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization.

Authors:  Florian Klein; Ron Diskin; Johannes F Scheid; Christian Gaebler; Hugo Mouquet; Ivelin S Georgiev; Marie Pancera; Tongqing Zhou; Reha-Baris Incesu; Brooks Zhongzheng Fu; Priyanthi N P Gnanapragasam; Thiago Y Oliveira; Michael S Seaman; Peter D Kwong; Pamela J Bjorkman; Michel C Nussenzweig
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

6.  Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Authors:  Xueling Wu; Zhi-Yong Yang; Yuxing Li; Carl-Magnus Hogerkorp; William R Schief; Michael S Seaman; Tongqing Zhou; Stephen D Schmidt; Lan Wu; Ling Xu; Nancy S Longo; Krisha McKee; Sijy O'Dell; Mark K Louder; Diane L Wycuff; Yu Feng; Martha Nason; Nicole Doria-Rose; Mark Connors; Peter D Kwong; Mario Roederer; Richard T Wyatt; Gary J Nabel; John R Mascola
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

Review 7.  Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies.

Authors:  Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

8.  Complete nucleotide sequence of bacteriophage MS2 RNA: primary and secondary structure of the replicase gene.

Authors:  W Fiers; R Contreras; F Duerinck; G Haegeman; D Iserentant; J Merregaert; W Min Jou; F Molemans; A Raeymaekers; A Van den Berghe; G Volckaert; M Ysebaert
Journal:  Nature       Date:  1976-04-08       Impact factor: 49.962

9.  SoDA2: a Hidden Markov Model approach for identification of immunoglobulin rearrangements.

Authors:  Supriya Munshaw; Thomas B Kepler
Journal:  Bioinformatics       Date:  2010-02-09       Impact factor: 6.937

10.  Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes.

Authors:  Bryan S Briney; Jordan R Willis; James E Crowe
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

View more
  51 in total

Review 1.  Computational tools for epitope vaccine design and evaluation.

Authors:  Linling He; Jiang Zhu
Journal:  Curr Opin Virol       Date:  2015-03-31       Impact factor: 7.090

2.  Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice.

Authors:  Sean A Gray; Margaret Moore; Emily J VandenEkart; Richard P Roque; Richard A Bowen; Neal Van Hoeven; Steven R Wiley; Christopher H Clegg
Journal:  Antiviral Res       Date:  2016-04-21       Impact factor: 5.970

Review 3.  The evolution within us.

Authors:  Sarah Cobey; Patrick Wilson; Frederick A Matsen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

4.  Long Single-Molecule Reads Can Resolve the Complexity of the Influenza Virus Composed of Rare, Closely Related Mutant Variants.

Authors:  Alexander Artyomenko; Nicholas C Wu; Serghei Mangul; Eleazar Eskin; Ren Sun; Alex Zelikovsky
Journal:  J Comput Biol       Date:  2016-11-30       Impact factor: 1.479

5.  Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.

Authors:  Juan Carlos Almagro; Gary L Gilliland; Felix Breden; Jamie K Scott; Devin Sok; Matthias Pauthner; Janice M Reichert; Gustavo Helguera; Raiees Andrabi; Robert Mabry; Mathieu Bléry; James E Voss; Juha Laurén; Lubna Abuqayyas; Stefan Barghorn; Eshel Ben-Jacob; James E Crowe; James S Huston; Stephen Albert Johnston; Eric Krauland; Fridtjof Lund-Johansen; Wayne A Marasco; Paul W H I Parren; Kai Y Xu
Journal:  MAbs       Date:  2014-03-03       Impact factor: 5.857

Review 6.  Integrating high-throughput screening and sequencing for monoclonal antibody discovery and engineering.

Authors:  Cristina Parola; Daniel Neumeier; Sai T Reddy
Journal:  Immunology       Date:  2017-10-30       Impact factor: 7.397

Review 7.  How repertoire data are changing antibody science.

Authors:  Claire Marks; Charlotte M Deane
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

8.  Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.

Authors:  Xueling Wu; Zhenhai Zhang; Chaim A Schramm; M Gordon Joyce; Young Do Kwon; Tongqing Zhou; Zizhang Sheng; Baoshan Zhang; Sijy O'Dell; Krisha McKee; Ivelin S Georgiev; Gwo-Yu Chuang; Nancy S Longo; Rebecca M Lynch; Kevin O Saunders; Cinque Soto; Sanjay Srivatsan; Yongping Yang; Robert T Bailer; Mark K Louder; James C Mullikin; Mark Connors; Peter D Kwong; John R Mascola; Lawrence Shapiro
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

Review 9.  HIV broadly neutralizing antibody targets.

Authors:  Constantinos Kurt Wibmer; Penny L Moore; Lynn Morris
Journal:  Curr Opin HIV AIDS       Date:  2015-05       Impact factor: 4.283

10.  Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor.

Authors:  Leopold Kong; Bin Ju; Yajing Chen; Linling He; Li Ren; Jiandong Liu; Kunxue Hong; Bin Su; Zheng Wang; Gabriel Ozorowski; Xiaolin Ji; Yuanzi Hua; Yanli Chen; Marc C Deller; Yanling Hao; Yi Feng; Fernando Garces; Richard Wilson; Kaifan Dai; Sijy O'Dell; Krisha McKee; John R Mascola; Andrew B Ward; Richard T Wyatt; Yuxing Li; Ian A Wilson; Jiang Zhu; Yiming Shao
Journal:  Immunity       Date:  2016-04-05       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.